Clovis Oncology’s Rubraca granted FDA priority review for advanced prostate cancer
BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the U.S. Food and Drug Administration (FDA) has accepted the companys supplemental New Drug Application (sNDA) for Rubraca ... Read More
Wednesday January 15, 2020 0 comments
Clovis: Rucaparib recommended for United Kingdom women with relapsed ovarian cancer
BOULDER -- Clovis Oncology, Inc . (NASDAQ: CLVS) announced the National Institute for Health and Care Excellence (NICE) has recommended that women with relapsed ovarian cancer in England have... Read More
Monday October 14, 2019 0 comments
Clovis Oncology submits NDA for rucaparib to treat recurrent ovarian cancer
BOULDER -- Clovis Oncology (NASDAQ: CLVS) today announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for rucaparib as maintenance... Read More
Tuesday October 10, 2017 0 comments
Clovis Oncology's rucaparib ovarian cancer drug granted FDA Breakthrough Therapy designation
BOULDER Clovis Oncology Inc. (NASDAQ: CLVS) announced the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for the companys investigational agent rucaparib as... Read More
Tuesday April 7, 2015 0 comments
CBSA investor and partnering conference shines spotlight on region's most promising bioscience firms
By Steve Porter InnovatioNews ... Read More
Friday September 20, 2013 1 comments
Investors announced for 2013 Rocky Mountain Life Science Investor and Partnering Conference
DENVER - More than 35 leading investors and strategic partners from across the U.S. will be attending the Rocky Mountain Life Science Investor and Partnering Conference in Denver on Sept. 19. ... Read More
Wednesday September 11, 2013 0 comments
Clovis Oncology and Foundation Medicine announce diagnostic collaboration
BOULDER - Clovis Oncology Inc. (Nasdaq: CLVS) and Foundation Medicine Inc. today announced they have entered into a collaboration aimed at developing an in-vitro diagnostic (IVD) to identify... Read More
Monday August 6, 2012 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
